GLYMAXAN
DEAD

Serial Number

88791393

Owner

Teva Pharmaceuticals USA, Inc.

Filing Date

Feb 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

GLYMAXAN Trademark

Serial Number: 88791393

GLYMAXAN is a trademark filed by Teva Pharmaceuticals USA, Inc. on February 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Teva Pharmaceuticals USA, Inc. (587 trademarks)

650 Cathill Road
Sellersville, PA 18960

Entity Type: 03

Trademark Details

Filing Date

February 10, 2020

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of pain, cardiovascular diseases, respiratory diseases, central nervous system disorders, gastrointestinal diseases, and metabolic syndrome; Pharmaceutical preparations, namely, anti-viral agents, immunosuppressant agents, and corticosteroids; pharmaceutical preparations for use in oncology and endocrinology; pharmaceutical preparations for use in women's health, namely, for the treatment of breast cancer and post-menopausal symptoms; oral contraceptives

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 8, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 8, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 26, 2020 GNFN
FINAL REFUSAL E-MAILED
Jun 26, 2020 GNFR
FINAL REFUSAL WRITTEN
Jun 26, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 27, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 18, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 18, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 18, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2020 NWOS
NEW APPLICATION ENTERED
Feb 13, 2020 NWAP